ReviewNature reviews. Microbiology2006
Global measles elimination.
Review in Nature reviews. Microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
112 citing papers in PubMed, 240 citations in OpenAlex.
- Measles susceptibility in a large urban center in Northeast Brazil and its implications for viral reintroduction risk.BMC public health · 2026Article
- Infectious medical waste (IMW) and disease transmission: A critical public health challenge in Africa and the global implications - A systematic review.Journal of public health research · 2026Article
- Measles seroprevalence among health care professionals during a period of increased transmission: A pilot study in Southern Italy.IJID regions · 2026Article
- Germline-Targeting Strategies to Induce bNAbs against HIV-1.Current HIV research · 2026Review
- Quarantine-associated viral pathogens in non-human primates: pathobiology, diagnostic surveillance, control strategies, and one health implications.Frontiers in veterinary science · 2026Review
- Risk Analysis of Measles Outbreaks in Bulgaria and Romania for the Period 2000 to 2023: A Comparative Study.Journal of epidemiology and global health · 2025Article
- Epidemiology, clinical overview, and potential risk of a new pandemic of measles virus.Infectious diseases & immunity · 2025Review
- Measles immunity gaps: distinct serological profiles from the United States and India.Journal of travel medicine · 2025Article
- Hospital-acquired infections and unvaccinated children due to chronic diseases: an investigation of the 2017-2019 measles outbreak in the northern region of Vietnam.BMC infectious diseases · 2024Article
- Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries.Vaccines · 2024Review
- Helical peptides with disordered regions for measles viruses provide new generalized insights into fusion inhibitors.iScience · 2024Article
- Effects of behavioral observability and social proof on the coupled epidemic-awareness dynamics in multiplex networks.PloS one · 2024Article
- Article
- Epidemiology of measles in Angola: Results from routine surveillance from 2015 to 2021.IJID regions · 2023Article
- Two centuries of vaccination: historical and conceptual approach and future perspectives.Frontiers in public health · 2023Review
- Analysis of the different interventions scenario for programmatic measles control in Bangladesh: A modelling study.PloS one · 2023Article
- Epidemiological and Clinical Characteristics of Measles in Jinan, Shandong Province, China, from 1991 to 2022.International journal of general medicine · 2023Article
- Measles second dose vaccine utilization and associated factors among children aged 24-35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys.BMC public health · 2022Article
- Breakthrough Infections: A Challenge towards Measles Elimination?Microorganisms · 2022Review
- Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.Molecular diagnosis & therapy · 2022Review
52 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Measles remains a leading vaccine-preventable cause of child mortality worldwide, particularly in sub-Saharan Africa where almost half of the estimated 454,000 measles deaths in 2004 occurred. However, great progress in measles control has been made in resource-poor countries through accelerated measles-control efforts. The global elimination of measles has been debated since measles vaccines were first licensed in the 1960's, and this debate is likely to be renewed if polio virus is eradicated. This review discusses the pathogenesis of measles and the likelihood of the worldwide elimination of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.